Novo Nordisk readies US rollout of Ozempic for type 2 diabetes
Novo Nordisk is set to launch oral Ozempic in the [...]
UK Alzheimer’s patients missing out on experimental treatments due to slow diagnoses
UK Alzheimer’s patients are missing out on experimental treatments because [...]
Over-85 population set to double in UK, new report shows
The UK’s over-85 population is set to double over the [...]
Agetech innovation round-up; featuring academia, business and research concerns.
LONGEVITY science is entering the mainstream with the launch of [...]
Study reveals 20 types of cancer on rise among young people
Cancer rates are rising among adults aged 20 to 49, [...]
Obesity tool could identify who would most benefit from weight loss drugs
A new obesity tool could help the NHS decide who [...]
Agetech science & society news round-up
Blue Zones are to be recognised in a new global [...]
Roundup: discover the latest in AI-preventative care and more
Age Tech World explores the latest business developments in the [...]
NHS rejects Alzheimer’s drugs over cost concerns
Two new Alzheimer’s drugs have been rejected for NHS use [...]
AI helps unravel a cause of Alzheimer’s disease and identify a therapeutic candidate
A new study found that a gene recently recognised as [...]
